ArticleProceedings of the National Academy of Sciences of the United States of America2012

Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target.

Yongyuth Yuthavong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.